OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2024-03-31-accounts

THE NORFOLK RENAL FUND

STATEMENT OF ACCOUNTS

FOR THE YEAR ENDED 31 MARCH 2024

THE NORFOLK RENAL FUND

TRUSTEES' ANNUAL REPORT

FOR THE YEAR ENDED 31 MARCH 2024

1. Name of charity: The Norfolk Renal Fund

2. Charity Number: 1045119

3. Principal Address: c/o Bankside 300 Peachman Way Broadland Business Park Norwich NR7 0LB

4. Governing Document:

5. Principal Objectives:

and

6. Investment Powers:

Trust monies requiring investment may be invested in the purchase of such stocks, funds, shares or securities or other investments of whatsoever nature as the trustees shall at their absolute discretion think fit.

However, at all times the trustees acknowledge the duty of care in the administration of Trust Funds and affairs.

-1-

THE NORFOLK RENAL FUND

TRUSTEES' ANNUAL REPORT (continued)

FOR THE YEAR ENDED 31 MARCH 2024

7. Trustees: Mr M Proctor - Treasurer Mr P Norton Dr M Andrews Dr M Karim Mr J Curtis

8. Appointment and induction of trustees:

Trustees are recruited on the basis that they will add appropriate skills to the existing group of trustees. Ideally, although this is not a requirement, the trustees as a group will have amongst their number a member with clinical expertises, a member serving as a patient representative as well as professional individuals who can provide external influence.

All new trustees are given a copy of the trust deed and the latest copy of the audited accounts, they are also provided with a copy of the Charity Commission publication CC3: The Essential Trustee - "What you need to know, What you need to do", to give them an overview of the responsibilities taken on when becoming trustees. Trustees are also encouraged to attend appropriate external training events where these will facilitate the undertaking of their role.

9. Organisation and administration:

The trustees aim to meet twice a year with a further virtual meeting by email, management accounts are prepared quarterly, and Dr M Andrews is responsible for the day to day administration.

10. Bankers: Barclays Bank plc 5/7 Red Lion Street Norwich NR1 3QH CCLA Investment Management Limited Senator House 85 Queen Victoria Street London EC4V 4ET 11. Independent Examiner: Elizabeth Claxton FCA FCCA TC Group Accountants Yare House 62-64 Thorpe Road Norwich Norfolk NR1 1RY

12. Solicitors: Hansells Solicitors Cambridge House 26 Tombland Norwich NR2 3RE 13. Financial Advisors: Lovewell Blake Financial Planning Limited Bankside 300 Peachman Way Broadland Business Park Norwich Norfolk NR7 0LB

-2-

THE NORFOLK RENAL FUND

TRUSTEES' ANNUAL REPORT (continued)

FOR THE YEAR ENDED 31 MARCH 2024

14. Review of the Year:

The Fund continued to provide Hardship payments for patients who need to seek financial support. This will continue in the forthcoming year.

A contribution was made towards the attendance of nurses at the Home Therapies Summit.

During the year the Fund made a contribution towards the Renal Unit staff Christmas Party in order to enhance the wellbeing of staff and promote team building.

Trustees will want to support the Renal Unit of the Norfolk and Norwich University Hospital in whatever position it might find itself in the future.

During the year the Trustees have continued to monitor the investment strategy to ensure the previous decision to look at more medium to long term investment strategies remains appropriate.

15. Risk management:

Risk management issues have been addressed and the trustees have procedures to mitigate risk.

16. Reserves policy:

It is the policy of the trustees to maintain the reserves of the charity at a level sufficient to cover anticipated future expenditure commitments and project costs for the year ahead. Currently reserves are significantly in excess of this, however, the trustees are expecting to fund specific future projects when they are requested by beneficiaries. The trustees have agreed to fund training and education projects within the Norwich Unit. In the forthcoming year the Fund will continue with its support of the above activities.

At the year end the unrestricted funds of the charity stand at £427,642 with restricted funds amounting to £55,061. Within the restricted funds is an amount detailed as 'Cromer Patients', these funds were raised by patients and their relatives to be used specifically for the renal unit of Cromer Hospital. At the current time consideration is being given as to the use of the remaining funds, plans are ongoing in association with other work at the Cromer site, due to the impact of Coronavirus, there have been delays in progressing this.

17. Public Benefit:

The trustees have paid due regard to the Charity Commission's guidance on public benefit in deciding what activities the charity should undertake.

Signed on behalf of the trustees

Mr P Norton Date: 30 January 2025

-3-

THE NORFOLK RENAL FUND

INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF THE NORFOLK RENAL FUND

FOR THE YEAR ENDED 31 MARCH 2024

I report on the accounts of the charity for the year ended 31 March 2024 which are set out on pages 5 to 9.

Responsibilities and basis of report

As the charity’s trustees you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011 (‘the Act’).

I report in respect of my examination of the charity’s accounts carried out under section 145 of the Act and in carrying out my examination I have followed all the applicable Directions given by the Charity Commission under section 145(5)(b) of the Act.

Independent examiner's statement

I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:

  1. accounting records were not kept in respect of the charity as required by section 130 of the Act; or

  2. the accounts do not accord with those records.

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

Elizabeth Claxton FCA FCCA TC Group Accountants Yare House 62-64 Thorpe Road Norwich Norfolk NR1 1RY

Date: 31 January 2025

-4-

THE NORFOLK RENAL FUND

RECEIPTS AND PAYMENTS ACCOUNT

FOR THE YEAR ENDED 31 MARCH 2024

Note
Income
Donations
Legacies
Interest
Direct Expenditure
2
Management and Administration
Administrative fees - current year
Administrative fees - prior year
Independent examiner fees
Online charitable giving fees
Postage and stationery
Honorarium
Investment charges
Website hosting
Reversal of previously issued cheque
(Deficit) / surplus of income over expenditure
Unrestricted
Restricted
Funds
Funds
£
£
11,462
-
-
50,266
29
-
11,491
50,266
2,060
-
9,431
50,266
1,704
1,332
1,740
216
44
250
2,961
407
(94)
8,560
871
50,266
2024
Unrestricted
Restricted
Funds
Funds
£
£
9,594
-
-
2,000
6
-
9,600
2,000
5,027
-
4,573
2,000
1,536
3,030
-
416
109
840
2,894
383
-
9,208
(4,635)
2,000
2023

-5-

THE NORFOLK RENAL FUND

STATEMENT OF ASSETS AND LIABILITIES

AS AT 31 MARCH 2024

Note
Accumulated Funds
Balance brought forward
(Deficit)/surplus of income over expenditure
Transfer from restricted funds
Movement on investments
Restricted Funds
3
Represented by
COIF Charities Investments
4
Cash held at bank
5
2024
£
384,817
871
-
385,688
41,954
427,642
55,061
482,703
390,576
92,127
482,703
2023
£
399,786
(4,635)
-
395,151
(10,334)
384,817
4,795
389,612
348,622
40,990
389,612

Signed on behalf of the trustees

Mr P Norton

Date: 30 January 2025

-6-

THE NORFOLK RENAL FUND

NOTES TO THE ACCOUNTS

FOR THE YEAR ENDED 31 MARCH 2024

1. Accounting Policies

General

The accounts have been prepared under the receipts and payments basis and the Charities Act 2011.

2. Direct Expenditure

Unrestricted Funds:
Attendance at Home Therapies Summit
Contribution to Renul Unit staff Christmas party
Contribution to conference attendance
Art Work
Norfolk Kidney Website
Petty cash
Hardship contributions
Restricted Funds:
-
2024
£
160
1,200
-
-
-
200
500
2,060
-
2,060
- 2023
£
-
-
1,000
3,269
158
500
100
5,027
-
5,027

-7-

THE NORFOLK RENAL FUND

NOTES TO THE ACCOUNTS (continued)

FOR THE YEAR ENDED 31 MARCH 2024

3. Restricted Funds

Cromer Unit
(Patient Funds)
Balance brought forward
Income
Interest received
Funds paid out
The Norfolk and Norwich Kidney Centre Fund
(formerly The Jack Pryor Unit Fund)
Balance brought forward
Funds introduced
Interest received
Dialysis Programme
Balance brought forward
Funds introduced
Interest received
Total
2024
£
3,446
-
-
-
3,446
1,349
-
-
1,349
-
50,266
-
50,266
55,061
2023
£
1,446
2,000
-
-
3,446
1,349
-
-
1,349
-
-
-
1,349
4,795

-8-

THE NORFOLK RENAL FUND

NOTES TO THE ACCOUNTS (continued)

FOR THE YEAR ENDED 31 MARCH 2024

4. Investment Portfolio

COIF Charities Fixed Interest Fund
COIF Charities Ethical Investment Fund
COIF Charities Investment Fund
COIF Charities Property Fund
COIF Charities Global Equity Income Fund
2024
£
87,282
82,369
65,521
34,429
120,975
390,576
2023
£
71,501
76,544
58,340
34,503
107,734
348,622

Realised and unrealised gains and losses on the COIF Charities portfolio are included within the above figures.

5. Cash Held at Bank

Barclays
Business Premium
Community Account
COIF
Charities Deposit Fund
2024
£
2,161
89,865
101
92,127
2023
£
2,076
38,818
96
40,990

6. Trustees' Remuneration and Expenses

No remuneration directly or indirectly out of the funds of the charity was paid or payable for the year to any trustee or to any person or persons known to be connected with any of them, other than the following amounts. Administration and other professional fees of £3,036 (2023: £4,566) were paid to Lovewell Blake LLP, a firm in which Mark Proctor, a trustee, is a partner.

During the year investment advice to the value of £2,961 (2023: £2,894) was provided to the charity by Lovewell Blake Financial Planning Limited, a company in which Mark Proctor has an interest through his partnership in Lovewell Blake LLP.

In the previous year to 31 March 2023 a contibution of £1,000 was paid to Dr M Andrews, a trustee, towards his attendance at a medical conference in Toronto, Canada.

No reimbursement of expenses has been made or is due to be made to any of the trustees in respect of the year.

-9-